265 related articles for article (PubMed ID: 20196148)
1. Azathioprine-induced hypersensitivity hepatitis: tolerance to 6-mercaptopurine.
Andrejic J; Rojas-Balcazar J; Dennis M; Berkelhammer C
Inflamm Bowel Dis; 2010 Nov; 16(11):1828-9. PubMed ID: 20196148
[No Abstract] [Full Text] [Related]
2. [Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].
Gisbert JP; Gomollón F; Maté J; Pajares JM
Gastroenterol Hepatol; 2002; 25(6):401-15. PubMed ID: 12069704
[No Abstract] [Full Text] [Related]
3. A Case of Thiopurine-Induced Acute Myocarditis in a Patient with Ulcerative Colitis.
Latushko A; Ghazi LJ
Dig Dis Sci; 2016 Dec; 61(12):3633-3634. PubMed ID: 27766449
[No Abstract] [Full Text] [Related]
4. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.
Ardizzone S; Maconi G; Russo A; Imbesi V; Colombo E; Bianchi Porro G
Gut; 2006 Jan; 55(1):47-53. PubMed ID: 15972298
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of azathioprine/6-mercaptopurine treatment in children with IBD is not necessary.
Griffiths AM
Inflamm Bowel Dis; 2003 Nov; 9(6):389-91; discussion 392-3. PubMed ID: 14671489
[No Abstract] [Full Text] [Related]
6. Azathioprine hypersensitivity presenting as sweet syndrome in a child with ulcerative colitis.
Kim MJ; Jang KT; Choe YH
Indian Pediatr; 2011 Dec; 48(12):969-71. PubMed ID: 22253154
[TBL] [Abstract][Full Text] [Related]
7. Tolerability and usefulness of mercaptopurine in azathioprine-intolerant Japanese patients with ulcerative colitis.
Kuriyama M; Kato J; Suzuki H; Akita M; Hiraoka S; Okada H; Yamamoto K
Dig Endosc; 2010 Oct; 22(4):289-96. PubMed ID: 21175481
[TBL] [Abstract][Full Text] [Related]
8. Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
Mottet C; Schoepfer AM; Juillerat P; Cosnes J; Froehlich F; Kessler-Brondolo V; Seibold F; Rogler G; Vavricka SR; Michetti P
Inflamm Bowel Dis; 2016 Nov; 22(11):2733-2747. PubMed ID: 27760078
[TBL] [Abstract][Full Text] [Related]
9. Severe muscular weakness: an unusual adverse effect of azathioprine therapy.
Karhadkar AS; Schwartz HJ; Arora M; Dutta SK
J Clin Gastroenterol; 2006 Aug; 40(7):626-8. PubMed ID: 16917406
[TBL] [Abstract][Full Text] [Related]
10. Poor response to thiopurine in inflammatory bowel disease: how to overcome therapeutic resistance?
Chouchana L; Roche D; Jian R; Beaune P; Loriot MA
Clin Chem; 2013 Jul; 59(7):1023-6. PubMed ID: 23813427
[No Abstract] [Full Text] [Related]
11. Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis.
Kader HA; Mascarenhas MR; Piccoli DA; Stouffer NO; Baldassano RN
J Pediatr Gastroenterol Nutr; 1999 Jan; 28(1):54-8. PubMed ID: 9890469
[TBL] [Abstract][Full Text] [Related]
12. Severe cholestatic acute hepatitis following azathioprine therapy in a patient with ulcerative pancolitis.
Roda G; Caponi A; Belluzzi A; Roda E
Dig Liver Dis; 2009 Dec; 41(12):914-5. PubMed ID: 19376754
[No Abstract] [Full Text] [Related]
13. Can azathioprine 6-mercaptopurine treatment be withdrawn in patients with response in ulcerative colitis: what is the most appropriate time for this?
Kabaçam G; Törüner M
Turk J Gastroenterol; 2012; 23 Suppl 2():17-20. PubMed ID: 23576085
[No Abstract] [Full Text] [Related]
14. 6-mercaptopurine as an alternative to azathioprine in azathioprine-induced hepatoxicity.
Kiefer K; El-Matary W
Inflamm Bowel Dis; 2009 Feb; 15(2):318-9. PubMed ID: 18989893
[No Abstract] [Full Text] [Related]
15. [Conservative therapy of ulcerative colitis--long-term experience].
Kölbel C; Goebell H
Internist (Berl); 1991 Sep; 32(9):530-9. PubMed ID: 1683664
[No Abstract] [Full Text] [Related]
16. How long should we treat patients with azathioprine/6-mercaptopurine before deciding that it is refractory to immunomodulatory treatment?
Kabaçam G; Törüner M
Turk J Gastroenterol; 2012; 23 Suppl 2():13-6. PubMed ID: 23576084
[No Abstract] [Full Text] [Related]
17. Leukocytapheresis in patients with moderate-severe steroid-dependant ulcerative colitis: clinical response without endoscopic response.
Modesto I; Scimeca D; Orlando A; Cottone M
Inflamm Bowel Dis; 2006 Oct; 12(10):1009-10. PubMed ID: 17012976
[No Abstract] [Full Text] [Related]
18. Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine.
Bowen DG; Selby WS
Dig Dis Sci; 2000 Sep; 45(9):1810-3. PubMed ID: 11052324
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of AZA/6-MP treatment in children with IBD is necessary.
Dubinsky MC
Inflamm Bowel Dis; 2003 Nov; 9(6):386-8; discussion 392-3. PubMed ID: 14671488
[No Abstract] [Full Text] [Related]
20. Immunosuppressive therapy for ulcerative colitis, ileitis, and granulomatous colitis.
Wisch N; Korelitz BI
Surg Clin North Am; 1972 Aug; 52(4):961-9. PubMed ID: 5047533
[No Abstract] [Full Text] [Related]
[Next] [New Search]
